Meghana Malkan of malkansview.com recommends buying Aurobindo Pharma with a target of Rs 210 and advises selling IRB Infrastructure Developers with a target of Rs 75.
first published: Sep 30, 2013 01:56 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty recovers 100 pts from day's low, metals under pressure | Closing Bell

Govt to stick to the path of fiscal consolidation - Prof Dev, PMEC chairman

Budget 2026 expectations: Taxpayers eye higher standard deduction, home loan interest relief

Live: Will Nifty take a breather after 3-day rally amid mixed global cues | Opening Bell
You are already a Moneycontrol Pro user.